World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
58007
World Ranking
7510
National Ranking
3921

Mark D. Fleming publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark D. Fleming sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 500 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark D. Fleming D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark D. Fleming sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark D. Fleming is affiliated with Boston Children's Hospital in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in Molecular Biology, Genetics, Hematology, Pediatrics, Perinatology and Child Health, and Epidemiology. This broad range informs their studies on various genetic and hematologic conditions.

The scientist's recent publications cover topics related to genetic pathways, epigenetics, immune response, and hematologic complications. Notable papers include:

  • Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome (2021, Nature Communications)
  • Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders (2021, Human Genetics and Genomics Advances)
  • Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection (2020, Med)
  • Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders (2022, Human Mutation)
  • Hematologic complications with age in Shwachman-Diamond syndrome (2021, Blood Advances)

Frequent co-authors in Fleming's work include Sarah Ducamp, Dean R. Campagna, Akiko Shimamura, Paul J. Schmidt, and Sioḃán Keel, indicating collaboration across multiple research clusters.

The scholar's publication record features contributions to venues such as Blood, bioRxiv (Cold Spring Harbor Laboratory), American Journal of Hematology, Human Genetics and Genomics Advances, and Human Mutation. These journals reflect a focus on hematologic and genetic research.

Research topics covered by Fleming frequently address biochemical and clinical aspects of blood and metabolism, with main topics including:

  • Porphyrin Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Heme Oxygenase-1 and Carbon Monoxide
  • Blood disorders and treatments
  • Folate and B Vitamins Research
  • Hemoglobinopathies and Related Disorders
  • Mitochondrial Function and Pathology

Overall, the work of Mark D. Fleming centers on advancing understanding of genetic and hematologic mechanisms and their clinical implications, with a focus on metabolic pathways and pediatric hematology.

Best Publications

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

    Jonathan E Rosenberg;Jean Hoffman-Censits;Tom Powles;Michiel S van der Heijden

  • The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

    Heather R. Christofk;Matthew G. Vander Heiden;Marian H. Harris;Arvind Ramanathan

  • p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

    Annie Yang;Mourad Kaghad;Yunmei Wang;Emily Gillett

  • Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

    Adriana Donovan;Alison Brownlie;Alison Brownlie;Yi Zhou;Jennifer Shepard

  • Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

    Jonathan B. Johnnidis;Marian H. Harris;Robert T. Wheeler;Sandra Stehling-Sun

  • Recurrent BRAF mutations in Langerhans cell histiocytosis

    Gayane Badalian-Very;Gayane Badalian-Very;Jo-Anne Vergilio;Jo-Anne Vergilio;Barbara A. Degar;Barbara A. Degar;Laura E. MacConaill

  • Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

    Y. Loriot;A. Necchi;S. H. Park;J. Garcia-Donas

  • Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells

    Brian Elenbaas;Lisa Spirio;Frederick Koerner;Mark D. Fleming

  • Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease

    David A. Weinstein;Cindy N. Roy;Mark D. Fleming;Massimo F. Loda

  • Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells.

    Robert S Ohgami;Dean R Campagna;Eric L Greer;Brendan Antiochos

  • Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.

    Merav Socolovsky;Hyung-song Nam;Mark D. Fleming;Volker H. Haase

  • Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

    Karin E Finberg;Matthew M Heeney;Matthew M Heeney;Dean R Campagna;Yeşim Aydınok

  • The Steap proteins are metalloreductases

    Robert S. Ohgami;Robert S. Ohgami;Dean R. Campagna;Dean R. Campagna;Alice McDonald;Alice McDonald;Mark D. Fleming;Mark D. Fleming

  • Myelopoiesis in the zebrafish, Danio rerio

    Carolyn M. Bennett;Carolyn M. Bennett;Carolyn M. Bennett;John P. Kanki;John P. Kanki;John P. Kanki;Jennifer Rhodes;Jennifer Rhodes;Jennifer Rhodes;Ting X. Liu;Ting X. Liu;Ting X. Liu

  • Telomerase contributes to tumorigenesis by a telomere length-independent mechanism

    Sheila A. Stewart;William C. Hahn;Benjamin F. O'Connor;Elisa N. Banner

  • The genomic landscape of pediatric Ewing sarcoma

    Brian D. Crompton;Chip Stewart;Amaro Taylor-Weiner;Gabriela Alexe

  • Measuring safety climate on offshore installations

    Kathryn Mearns;Rhona Flin;Rachale Gordon;Mark Fleming

  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

    Thomas Powles;Thomas Powles;Tibor Csőszi;Mustafa Özgüroğlu;Nobuaki Matsubara

  • Heme-regulated eIF2α kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency

    An-Ping Han;Channing Yu;Linrong Lu;Yuko Fujiwara

Frequent Co-Authors

Peter Gloviczki
Peter Gloviczki Mayo Clinic
Thomas C. Bower
Thomas C. Bower Mayo Clinic
Nancy C. Andrews
Nancy C. Andrews Duke University
Benjamin L. Ebert
Benjamin L. Ebert Harvard University
Akiko Shimamura
Akiko Shimamura Harvard University
Geraldine S. Pinkus
Geraldine S. Pinkus Brigham and Women's Hospital
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center
Catherine J. Wu
Catherine J. Wu Harvard University
Donna Neuberg
Donna Neuberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field in the USA offers numerous online degree options and career pathways for those pursuing or considering healthcare professions. If you’re exploring alternative routes to medicine, a popular choice is the online direct entry msn. These programs are tailored for non-nurses seeking a fast-track to advanced nursing roles, with flexible learning schedules ideal for working adults.

Entry into nursing schools can be competitive, but there are nursing schools with high acceptance rates that provide more accessible admission processes without compromising educational quality.

For those interested in administrative healthcare roles, the best online medical billing and coding schools offer accredited programs with financial aid, preparing graduates for in-demand positions in healthcare management.

Additionally, students who wish to join the nursing profession quickly may consider an lpn program without teas test requirements. These programs streamline the admissions process and make healthcare education more accessible for aspiring nurses.

Best Scientists Citing Mark D. Fleming

Trending Scientists

Recently Published Articles